62.5 F
Los Angeles
Friday, Jun 9, 2023

Every 180 Seconds Someone in the U.S. is Diagnosed with a Blood Cancer

Custom Content by the Los Angeles Business Journal

Every 180 seconds, someone in the U.S. has their life turned upside down by a blood cancer diagnosis. When this happens, The Leukemia & Lymphoma Society (LLS), the global leader in the fight against blood cancers, is there, providing guidance, education, and support every step of the way.

Despite the challenges of the COVID-19 pandemic, LLS has remained laser-focused on its mission priorities: Research, Education & Support and Policy & Advocacy.

Advancing the most promising blood cancer research worldwide
LLS is an unstoppable innovator, driving research worldwide to deliver next-generation breakthroughs and cures. From pioneering the first collaborative precision medicine clinical trial in a blood cancer to supporting the rise of CAR T-cell immunotherapies, LLS is an early adopter of the most cutting-edge treatment technologies and approaches.

Since 1949, LLS has invested more than $1.3 billion in cancer research, leading to breakthroughs in immunotherapy, genomics and personalized medicine that are improving and saving the lives of patients. The organization has helped advance 85% of the blood cancer treatment options approved by the U.S. Food and Drug Administration since 2017 alone.

Helping patients access the care they need

LLS is the leading source of free blood cancer information, education, and support for patients, survivors, caregivers, families, and healthcare professionals. The organization urges patients to learn about its free, one-on-one support, including:
• LLS Information Specialists are highly trained oncology professionals who provide free, personalized assistance to patients, families, and healthcare providers. LLS Information Specialists are ready to help at (800) 955-4572, Monday to Friday, 9 a.m. to 9 p.m. ET or by live chat/email on LLS.ORG.
• LLS Clinical Trial Nurse Navigators are registered nurses with expertise in blood cancers who conduct comprehensive clinical trial searches and personally assist patients, parents, and caregivers throughout the entire clinical trial process.
• LLS’s registered dietitian has expertise in oncology nutrition and provides patients, parents, and caregivers with free nutrition consultations.

LLS also offers financial assistance, a podcast, peer-to-peer support, online chats, webcasts, videos, caregiver support, education and outreach programs like Myeloma Link, and so much more.

Through a nationwide grassroots network of more than 30,000 active online volunteers, LLS advocates for policies at the state and federal level and is taking action to reduce patients’ out-of-pocket costs, address financial toxicity, and protect public health and cancer patients, during this crisis and beyond.

Taking on pediatric blood cancers from every direction
Through The LLS Children’s Initiative, a $160 million multi-year endeavor, LLS is taking on children’s cancer from every direction. The LLS Children’s Initiative includes: more dedicated pediatric blood cancer research, expanded education and support for children, young adults, and families, bold advocacy endeavors, and LLS PedAL, the first global precision medicine clinical trial for pediatric acute leukemia, with an anticipated launch later this year.

Fueling medical breakthroughs
To fuel its mission, LLS relies on the support of dedicated volunteers and donors, including everyone who participates in one of its groundbreaking fundraising campaigns like Man & Woman of the Year — a nationwide philanthropic competition in which thousands of individuals from diverse backgrounds come together for an exciting 10 weeks of creative fundraising efforts to fight blood cancer. Because of their commitment, LLS has played a role in advancing nearly every breakthrough in blood cancer research today.

“Advancing and accelerating our mission wouldn’t be possible without the relentless volunteers and supporters who raise critical funds through campaigns like Man & Woman of the Year,” said Louis J. DeGennaro, Ph.D., LLS president and CEO.

“Together, our work is fueling medical breakthroughs across the cancer landscape. At LLS, we have the power, the passion, and the resolve to ensure blood cancer patients live longer, better lives.”

To learn more, visit www.LLS.org.

Return to Index.

Featured Articles

Related Articles